Clinical profile and prognosis of elderly patients with left ventricular thrombus after anticoagulation
Abstract Background Contemporary data regarding the clinical characteristics and prognosis of left ventricular thrombus (LVT) in older adults (aged ≥ 65 years old) are lacking. In this study, we characterized elderly patients with LVT (aged ≥ 65 years old) and investigated the long-term prognosis in...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2023-07-01
|
| Series: | Thrombosis Journal |
| Subjects: | |
| Online Access: | https://doi.org/10.1186/s12959-023-00520-4 |
| _version_ | 1797778689085145088 |
|---|---|
| author | Qian Zhang Zhongfan Zhang Haikuo Zheng Chengbing Wang Miao Yu Daoyuan Si Wenqi Zhang |
| author_facet | Qian Zhang Zhongfan Zhang Haikuo Zheng Chengbing Wang Miao Yu Daoyuan Si Wenqi Zhang |
| author_sort | Qian Zhang |
| collection | DOAJ |
| description | Abstract Background Contemporary data regarding the clinical characteristics and prognosis of left ventricular thrombus (LVT) in older adults (aged ≥ 65 years old) are lacking. In this study, we characterized elderly patients with LVT (aged ≥ 65 years old) and investigated the long-term prognosis in this highly vulnerable patient population. Methods This single-center, retrospective study was conducted from January 2017 to December 2022. Patients with a reported LVT were assessed primarily by transthoracic echocardiography (TEE) and classified into two groups: elderly LVT groups and younger LVT groups. All patients were treated with anticoagulant treatment. Major adverse cardiovascular event (MACE) was defined as the composite of all-cause mortality, systemic embolism, and rehospitalization for cardiovascular events. Survival analyses were performed with the Kaplan-Meier method and Cox proportional-hazard model. Results A total of 315 eligible patients were included. Compared to the younger LVT group (n = 171), the elderly LVT group (n = 144) had a lower proportion of males and lower serum creatinine clearance, as well as a higher level of NT-proBNP, and a higher rate of history of systemic embolism. LVT resolution occurred in 59.7% and 69.0% of patients in the elderly LVT group and younger LVT group, respectively, with no significant difference (adjusted HR, 0.97; 95% CI, 0.74–1.28; P = 0.836). Yet, elderly patients with LVT, had higher prevalence rates of MACE (adjusted HR, 1.52; 95% CI, 1.10–2.11; P = 0.012), systemic embolism (adjusted HR, 2.81; 95% CI, 1.20–6.59; P = 0.017) and all-cause mortality (adjusted HR, 2.20; 95% CI, 1.29–3.74; P = 0.004) compared with younger patients with LVT. After adjusting for mortality in the Fine–Gray model, similar results were observed. Additionally, patients treated with different anticoagulation therapies (DOACs vs. warfarin) achieved a similar improvement in prognosis (P > 0.05) or LVT resolution (P > 0.05) in elderly patients with LVT. Conclusions Our results found that elderly patients experiencing LVT have a poor prognosis compared with the younger ones. Clinical prognosis in elderly patients did not significantly differ with the type of anticoagulant used. With aging societies worldwide, further evidence of antithrombotic therapy in elderly individuals with LVT is necessary. |
| first_indexed | 2024-03-12T23:21:04Z |
| format | Article |
| id | doaj.art-344ec79ded934d4eb031b1ee644944b1 |
| institution | Directory Open Access Journal |
| issn | 1477-9560 |
| language | English |
| last_indexed | 2024-03-12T23:21:04Z |
| publishDate | 2023-07-01 |
| publisher | BMC |
| record_format | Article |
| series | Thrombosis Journal |
| spelling | doaj.art-344ec79ded934d4eb031b1ee644944b12023-07-16T11:25:13ZengBMCThrombosis Journal1477-95602023-07-012111910.1186/s12959-023-00520-4Clinical profile and prognosis of elderly patients with left ventricular thrombus after anticoagulationQian Zhang0Zhongfan Zhang1Haikuo Zheng2Chengbing Wang3Miao Yu4Daoyuan Si5Wenqi Zhang6Department of Cardiology, China-Japan Union Hospital of Jilin University, Jilin Provincial Molecular Biology Research Center for Precision Medicine of Major Cardiovascular DiseaseDepartment of Cardiology, China-Japan Union Hospital of Jilin University, Jilin Provincial Molecular Biology Research Center for Precision Medicine of Major Cardiovascular DiseaseDepartment of Cardiology, China-Japan Union Hospital of Jilin University, Jilin Provincial Molecular Biology Research Center for Precision Medicine of Major Cardiovascular DiseaseDepartment of Neurology, China-Japan Union Hospital of Jilin University, ChangchunDepartment of Cardiology, China-Japan Union Hospital of Jilin University, Jilin Provincial Molecular Biology Research Center for Precision Medicine of Major Cardiovascular DiseaseDepartment of Cardiology, China-Japan Union Hospital of Jilin University, Jilin Provincial Molecular Biology Research Center for Precision Medicine of Major Cardiovascular DiseaseDepartment of Cardiology, China-Japan Union Hospital of Jilin University, Jilin Provincial Molecular Biology Research Center for Precision Medicine of Major Cardiovascular DiseaseAbstract Background Contemporary data regarding the clinical characteristics and prognosis of left ventricular thrombus (LVT) in older adults (aged ≥ 65 years old) are lacking. In this study, we characterized elderly patients with LVT (aged ≥ 65 years old) and investigated the long-term prognosis in this highly vulnerable patient population. Methods This single-center, retrospective study was conducted from January 2017 to December 2022. Patients with a reported LVT were assessed primarily by transthoracic echocardiography (TEE) and classified into two groups: elderly LVT groups and younger LVT groups. All patients were treated with anticoagulant treatment. Major adverse cardiovascular event (MACE) was defined as the composite of all-cause mortality, systemic embolism, and rehospitalization for cardiovascular events. Survival analyses were performed with the Kaplan-Meier method and Cox proportional-hazard model. Results A total of 315 eligible patients were included. Compared to the younger LVT group (n = 171), the elderly LVT group (n = 144) had a lower proportion of males and lower serum creatinine clearance, as well as a higher level of NT-proBNP, and a higher rate of history of systemic embolism. LVT resolution occurred in 59.7% and 69.0% of patients in the elderly LVT group and younger LVT group, respectively, with no significant difference (adjusted HR, 0.97; 95% CI, 0.74–1.28; P = 0.836). Yet, elderly patients with LVT, had higher prevalence rates of MACE (adjusted HR, 1.52; 95% CI, 1.10–2.11; P = 0.012), systemic embolism (adjusted HR, 2.81; 95% CI, 1.20–6.59; P = 0.017) and all-cause mortality (adjusted HR, 2.20; 95% CI, 1.29–3.74; P = 0.004) compared with younger patients with LVT. After adjusting for mortality in the Fine–Gray model, similar results were observed. Additionally, patients treated with different anticoagulation therapies (DOACs vs. warfarin) achieved a similar improvement in prognosis (P > 0.05) or LVT resolution (P > 0.05) in elderly patients with LVT. Conclusions Our results found that elderly patients experiencing LVT have a poor prognosis compared with the younger ones. Clinical prognosis in elderly patients did not significantly differ with the type of anticoagulant used. With aging societies worldwide, further evidence of antithrombotic therapy in elderly individuals with LVT is necessary.https://doi.org/10.1186/s12959-023-00520-4Left ventricular thrombusElderly patientsPrognosisAnticoagulation |
| spellingShingle | Qian Zhang Zhongfan Zhang Haikuo Zheng Chengbing Wang Miao Yu Daoyuan Si Wenqi Zhang Clinical profile and prognosis of elderly patients with left ventricular thrombus after anticoagulation Thrombosis Journal Left ventricular thrombus Elderly patients Prognosis Anticoagulation |
| title | Clinical profile and prognosis of elderly patients with left ventricular thrombus after anticoagulation |
| title_full | Clinical profile and prognosis of elderly patients with left ventricular thrombus after anticoagulation |
| title_fullStr | Clinical profile and prognosis of elderly patients with left ventricular thrombus after anticoagulation |
| title_full_unstemmed | Clinical profile and prognosis of elderly patients with left ventricular thrombus after anticoagulation |
| title_short | Clinical profile and prognosis of elderly patients with left ventricular thrombus after anticoagulation |
| title_sort | clinical profile and prognosis of elderly patients with left ventricular thrombus after anticoagulation |
| topic | Left ventricular thrombus Elderly patients Prognosis Anticoagulation |
| url | https://doi.org/10.1186/s12959-023-00520-4 |
| work_keys_str_mv | AT qianzhang clinicalprofileandprognosisofelderlypatientswithleftventricularthrombusafteranticoagulation AT zhongfanzhang clinicalprofileandprognosisofelderlypatientswithleftventricularthrombusafteranticoagulation AT haikuozheng clinicalprofileandprognosisofelderlypatientswithleftventricularthrombusafteranticoagulation AT chengbingwang clinicalprofileandprognosisofelderlypatientswithleftventricularthrombusafteranticoagulation AT miaoyu clinicalprofileandprognosisofelderlypatientswithleftventricularthrombusafteranticoagulation AT daoyuansi clinicalprofileandprognosisofelderlypatientswithleftventricularthrombusafteranticoagulation AT wenqizhang clinicalprofileandprognosisofelderlypatientswithleftventricularthrombusafteranticoagulation |